Financial Advocates Investment Management Buys New Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Financial Advocates Investment Management bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, Holdings Channel.com reports. The firm bought 11,968 shares of the exchange traded fund’s stock, valued at approximately $1,300,000.

Several other institutional investors also recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after acquiring an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC increased its position in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares in the last quarter. Bessemer Group Inc. increased its position in SPDR S&P Biotech ETF by 1.7% during the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after buying an additional 15,794 shares in the last quarter. Finally, Employees Retirement System of Texas increased its holdings in shares of SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.4 %

SPDR S&P Biotech ETF stock opened at $97.01 on Friday. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day simple moving average of $98.92 and a two-hundred day simple moving average of $94.82. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.